Chemomab Therapeutics Ltd. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.63 | $56.28 M | -5.86 | 2 | $0 |
BDRX
Biodexa Pharmaceuticals Plc |
$4.16 | $222,107 | -0.09 | 21 | $381,000 |
BOLT
Bolt Biotherapeutics, Inc. |
$0.52 | $29.02 M | -0.46 | 100 | $7.88 M |
CINGW
Cingulate Inc. |
$0.08 | $4.47 M | -0.01 | 13 | $0 |
CLRB
Cellectar Biosciences, Inc. |
$0.25 | $119.38 M | -1.08 | 20 | $0 |
CVKD
Cadrenal Therapeutics, Inc. Common Stock |
$16.35 | $7.53 M | 0 | 4 | $0 |
ELDN
Eledon Pharmaceuticals, Inc. |
$4.04 | $107.05 M | -2.26 | 20 | $0 |
HILS
Hillstream BioPharma, Inc. |
$0.24 | $4.17 M | -0.34 | 1 | $0 |
LBPH
Longboard Pharmaceuticals, Inc. |
$59.98 | $682.34 M | -7.8 | 50 | $0 |
LEXX
Lexaria Bioscience Corp. |
$2.00 | $46.84 M | -4.88 | 5 | $464,278 |
LUMO
Lumos Pharma, Inc. |
$4.34 | $20.13 M | -0.54 | 30 | $2.05 M |
MNPR
Monopar Therapeutics Inc. |
$25.45 | $14.18 M | -1.56 | 9 | $0 |
NAVB
Navidea Biopharmaceuticals, Inc. |
$0.00 | $10,008 | 0 | 11 | $65,652 |
NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 | $0 |
ONCR
Oncorus, Inc. |
$0.13 | $3.29 M | -0.04 | 64 | $0 |
QNRX
Quoin Pharmaceuticals, Ltd. |
$0.56 | $2.73 M | -0.11 | 4 | $0 |
RNXT
RenovoRx, Inc. |
$1.35 | $24.43 M | -1.46 | 8 | $0 |
SABS
SAB Biotherapeutics, Inc. |
$3.54 | $27.17 M | -0.44 | 57 | $2.24 M |
SNTI
Senti Biosciences, Inc. |
$3.87 | $12.84 M | -0.15 | 48 | $2.56 M |
ZVSA
ZyVersa Therapeutics, Inc. |
$1.44 | $3.68 M | 0 | 7 | $0 |